KIM-1 and NGAL: new markers of obstructive nephropathy by Wasilewska, Anna et al.
ORIGINAL ARTICLE
KIM-1 and NGAL: new markers of obstructive nephropathy
Anna Wasilewska & Katarzyna Taranta-Janusz &
Wojciech Dębek & Walentyna Zoch-Zwierz &
Elżbieta Kuroczycka-Saniutycz
Received: 6 December 2010 /Revised: 5 January 2011 /Accepted: 6 January 2011 /Published online: 31 January 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Congenital obstructivenephropathyistheprimary
cause of chronic renal failure in children. Rapid diagnosis
and initiation of the treatment are vital to preserve function
and/ortoslowdownrenal injury.Theaimofourstudywasto
determine whether urinary (u) kidney injury molecule-1
(KIM-1) and neutrophil gelatinase-associated lipocalin
(NGAL) may be useful non-invasive biomarkers in children
with congenital hydronephrosis (HN) caused by ureter-
opelvic junction obstruction. The study cohort consisted of
20 children with severe HN who required surgery (median
age 2.16 years) and two control groups (control group 1: 20
patients with mild, non-obstructive HN; control group 2: 25
healthy children). All of the children had normal renal
function. Immunoenzymatic ELISA commercial kits were
used to measure uKIM-1 and uNGAL concentrations. The
preoperative median uKIM-1/creatinine (cr.) and uNGAL
levels were significantly greater in the children with severe
HN than in both control groups. Three months after
surgery, uNGAL had decreased significantly (p<0.05) in
the children with severe HN, but was still higher than that
in control group 2 children (p<0.05). Receiver operator
characteristic analyses revealed a good diagnostic profile
for uKIM-1 and uNGAL in terms of identifying a
differential renal function of <40% in HN patients (area
under the curve (AUC) 0.8 and 0.814, respectively) and
<45% in all examined children (AUC 0.779 and 0.868,
respectively). Based on these results, we suggest that
increasing uNGAL and uKIM-1 levels are associated with
worsening obstruction. Further studies are required to
confirm a potential application of uKIM-1 and uNGAL as
useful biomarkers for the diagnosis and progression of
chronic kidney disease.
Keywords Children.Kidney injury molecule-1.
Neutrophil gelatinase-associated lipocalin.Ureteropelvic
junction obstruction.Chronic renal failure
Introduction
According to data of The North American Pediatric Renal
Transplant Cooperative Study (NAPRTCS), obstructive
nephropathy due to congenital or acquired urinary tract
obstruction is the first primary cause of chronic renal failure
(CRF) in children [1].
Congenital obstructive nephropathy results from malde-
velopment of the urinary tract in the fetus, with the most
common lesion being localized to the ureteropelvic junction
(UPJ). The prevalence of this abnormality in children is 1 in
1500 of the general population [2]. The etiology of UPJ
obstruction (UPJO) is multifactorial and polygenic, similar
to most other anomalies of the urinary tract. Chronic
urinary tract obstruction leads to progression of the renal
injury, even after surgical management of the obstruction.
Currently available clinical tests, including renal ultra-
sonography, nuclide renal scans or plasma, and urine
creatinine concentration are not good predictors of the
future course of the disease, stressing the urgent need for
new, simple markers of obstructive nephropathy that may
be useful in the clinical assessment of the suitability of
patients for surgical therapy and renoprotective interven-
tion. Plasma or urine markers, including neutrophil
gelatinase-associated lipocalin (NGAL), cystatin C, and
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DOI 10.1007/s00467-011-1773-5asymmetric dimethylarginine (ADMA), are recognized as
the most promising potential biomarkers for the early
detection and monitoring of acute kidney injury (AKI)
and chronic kidney disease (CKD) [3]. More recently, the
interest of clinicians has focused on the potential of kidney
injury molecule-1 (KIM-1) as a biomarker. In this study we
assessed the urine concentration of KIM-1 and NGAL
molecules as markers of renal function in children with
congenital hydronephrosis (HN).
NGAL (also known as lipocalin-2, siderocalin, uteroca-
lin, and 24p3) belongs to the lipocalin family [4]. However,
like many other endogenous biomarker molecules, it is not
produced by one cell type. This ubiquitous 25-kDa protein
is secreted by various types of human tissues, including the
gastrointestinal tract, respiratory tract, and the kidneys. In
the kidneys, NGAL is secreted into the urine by the thick
ascending limb of loop of Henle and collecting ducts of the
kidney, with synthesis in the distal nephron [5, 6]. Because
of its small molecular size, NGAL is freely filtered and can
be easily detected in urine. Urinary NGAL (uNGAL) is a
very early and sensitive biomarker of kidney injury, and
various studies have reported that uNGAL levels are
markedly increased in AKI, diabetic nephropathy, nephritic
syndrome, tubulointerstitial nephritis, and immunoglobulin
A (IgA) nephropathy (IgAN) [7–9].
KIM-1 is a type I transmembrane glycoprotein with an
ecto-domain containing both an Ig-like and a mucin
domain. It was discovered in renal tubular epithelial cells
in a screen for molecules involved in the pathogenesis of
AKI [10]. In healthy kidneys, KIM-1 is undetectable.
However, the increased expression of this protein was
found at very high levels on the apical membrane of
proximal tubule cells after ischemic and nephrotoxic injury
[10, 11]. KIM-1 expression is absent in the glomerulus,
peritubular interstitial cells, or inner medullary cells [10,
12]. Another characteristic of KIM-1 that make it an ideal
biomarker for kidney injury is the rapid and integrated
cleavage of its ecto-domain into the lumens of kidneys
tubules, which can make it detectable in urine [13]. The
uKIM-1 level has been documented to be closely related to
tissue KIM-1 level and to correlate with kidney tissue
damage [14]. Clinical studies have documented that KIM-1
is upregulated in tubules of patients with focal glomerulo-
sclerosis, IgA nephropathy, or membranoproliferative glo-
merulonephritis [15] and that it is associated with
proteinuria and its consequences, such as tubular injury
and interstitial fibrosis [15]. These results have led to the
suggestion that uKIM-1 may be a promising, non-invasive
biomarker of chronic tubulointerstitial damage.
The aim of the case–control study reported here was to
evaluate uKIM-1 and uNGAL levels in young children and
adolescents affected by severe congenital HN caused by
UPJO. We also assessed the possible clinical application of
uKIM-1 and uNGAL as non-invasive diagnostic and
predictive biomarkers in UPJO.
Patients and methods
Patients
This was a case–control prospective study performed in
children with severe congenital HN caused by UPJO, who
were diagnosed at the Department of Pediatrics and
Nephrology and treated at the Pediatric Surgery Department
of the Medical University of Białystok, Poland. The study
was performed from January 2008 to February 2010.
Healthy children were chosen from those referred to a
pediatric outpatient clinic of the Children’s University
Hospital, Białystok, Poland, where all children are period-
ically monitored for their development and growth. All
caregivers of the children were interviewed and gave
informed consent for the children to participate in the study.
The children were categorized into three groups: one
study group and two types of control groups. The study
group included 20 children (15 boys, 5 girls; median age
2.16 years, range 0.16–17 years) with severe HN due to
unilateral, critical degree ureteral stenosis, who underwent
pyeloplasty by the Anderson–Hynes method. The first
control group (control 1) included 20 children with mild,
non-obstructive HN who did not require surgery (median
age 8.75 years); these children had suspected but not
confirmed UPJO. The second control group (control 2)
consisted of 25 healthy children (14 boys, 11 girls; median
age 5.0 years, range 0.33–16 years). All the children had a
normal ultrasound examination of the kidney.
Health status was determined on the basis of the
subjects’ medical history, parental report, and routine
laboratory examinations to rule out the presence of acute
or chronic disease. The UPJO was confirmed with
radionuclide renal scans. Criteria for pyeloplasty included
positive findings on the clinical, ultrasound, and radionu-
clide scan evaluation. Renal ultrasound (US) was used as an
initial diagnostic tool to detect HN. All US examinations
were performed by a pediatric radiologist using a SSA–
280A scanner (Toshiba, Tokyo, Japan) equipped with a
3.5–MHz probe. The degree of HN was graded according
to the Society for Fetal Urology (SFU) classification: grade
1 represents a split pelvis; grade 2 is further dilation of the
renal pelvis, with a few visualized calyces permissible;
grade 3 is renal pelvis dilation, with many distended
calyces; grade 4 is a grade 3 appearance with the addition
of thinned parenchyma [16]. Vesicoureteral reflux was
ruled out in all patients by voiding cystourethrography
(VCUG). The diagnosis of non-obstructive HN was made
when there was (1) no change in differential renal function
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99m mercaptoacetyltriglycine (99mTc–MAG3) diuretic
renography and (2) stationary HN on the US scan.
Criteriaforinclusioninthestudygroupwere:(1)anageof
1 month to 18 years; (2) unilateral pelvicaliceal system (PCS)
dilatation;(3)a99mTc–MAG3diureticrenogram(furosemide
washout test) that suggested unilateral UPJ obstruction (study
group)anddifferentialrenalfunction(DRF)available.ADRF
ofthe affected dilated kidneyof ≥45% was considerednormal
and a DRF of <45% was considered abnormal. Exclusion
criteria were associated anomalies, including vesicoureteral
reflux, ureterovesical junction obstruction and posterior
urethral valves obstruction, bilateral HN, previous operation
on the urinary system and other deformations of the external
genital organs, deformations in the lower part of the ureter,
bladder, and urethra, urinary stones, neurogenic bladder
dysfunction, and “supranormal function” of the affected
kidney (DRF >55%).
In the study group the urine samples were collected
three times: the first morning voided urine samples
obtained preoperatively (exam A); urine samples from
affected pelvis obtained during the surgery (exam B); first
morning voided urine samples collected 3 months after
surgery (exam C). The clinical work-up included the
analysis of medical charts to determine age, gender,
laterality, and grade of hydronephrosis, anteroposterior
(AP) pelvic diameter, age at diagnosis, method of treatment,
measurement of height, weight, blood pressure, and
physical examination. The biochemical work-up included
the determination of serum creatinine concentration (mea-
sured by the Jaffe reaction), urea, glomerular filtration rate
(ml/min/1.73 m
2), estimated by the Schwartz formula
(eGFR): GFR=k × G (cm)/Lcr (mg/dl), where k is the
age-dependent coefficient (0.55 in boys <12 years old and
girlsatanyage,0.7inboys>12yearsofage),Gisgrowth,and
Lcr is the level of creatinine in serum. The urine was
aseptically collected between 7 and 8 am from the morning
sample. Measurements of uKIM-1 and uNGAL were per-
formed in samples frozen at−80°C. Patients with pathological
leukocyturia were excluded from the examination.
Methods
KIM-1 ELISA assay uKIM-1 was determined using a
commercially available enzyme-linked immunosorbent as-
say (ELISA) test kit (USCN Life Science, Hankou, Wuhan,
China) and was expressed in nanograms per milligram
creatinine (ng/mg cr.). In brief, a biotinylated polyclonal
antibody specific for KIM-1 was used to detect KIM-1 in
the urine samples. Horseradish peroxidase-conjugated
avidin was added, followed by a color-forming peroxidase
substrate containing tetramethylbenzidine. The color was
then measured at 450 nm by a microtiter plate reader and
compared with a standard curve. KIM-1 levels below the
detection level were scored as 0.07 ng/ml.
NGAL ELISA assay uNGAL was measured using a
commercially available ELISA kit (BioPorto Diagnostics,
Gentofte, Denmark) according to manufacturer instructions.
The enzymatic reaction was quantified in an automatic
microplate photometer. The urinary creatinine concentration
was used to normalize NGAL measurements to account for
the influence of urinary dilution on its concentration.
uNGAL levels were expressed as uNGAL/cr. ratio in
nanograms per milligram creatinine (ng/mg cr.). The mean
intra- and inter-assay coefficients of variation for NGAL
were 3.6 and 7.9%, respectively. The detection limit was a
mean of 0.012 ng/ml.
Statistics
Data analysis was performed using the computer program
Statistica ver. 9.0 (SPSS, Chicago, IL). Nonparametric
statistics was chosen as the patient population of this study
was relatively small. Statistical analysis was performed
using the nonparametric Mann–Whitney U test. Differences
between the treatments were analyzed by Friedman’s
analysis of variance (ANOVA) for repeated measures. The
receiver operating characteristic (ROC) curve was used to
determine the cut-off values of uKIM-1 and uNGAL that
gave the best sensitivity and specificity. Correlations
between uNGAL and other variables were evaluated by
the Pearson or Spearman test as appropriate.
Ethics statement
The study was approved by the ethics committee of the
Medical University of Białystok in accordance with the
Declaration of Helsinki. Written informed consent was
obtained from all parents following an explanation of the
purpose of the study.
Results
The demographic and clinical data for each group are
summarized in Table 1. In our study cohort, boys were
more frequently affected with HN than girls; this gender
bias has also been reported in the literature [17]. The left
kidney was more commonly involved than the right kidney
(26:14, respectively). Grade 1 HN was present in four
children (10%), and grades 2, 3, and 4 HN were present in
11 (27.5%), 14 (35%), and 11 (27.5%) children, respec-
tively. Mean age at surgery was approximately 2 years. The
DRF in the study group ranged from 10.2 to 45% (median
Pediatr Nephrol (2011) 26:579–586 58139%) and was significantly lower than that in patients from
control 1 (p<0.05). The pelvis length was found to be
significantly higher in study group than in control 1 children
(p<0.05). A radionuclide scan was not performed in healthy
children, so the DRF was not assessed in this group.
Table 2 and Fig. 1 show that the preoperative uKIM-1/ cr.
levels from voided urine (exam A) and the affected pelvis
(exam B) were significantly greater than those in both control
groups: exam A, median 3.13 (range 0.6–10.73) ng/mg cr.;
exam B, median 3.42 (range 0.19–9.59) ng/mg cr. versus
control 1, median 1.04 (range 0.18–5.69, p<0.05) ng/mg cr.
and control 2, median 0.58 (0.15–3.01 ng/ mg cr., p<0.01).
Three months after surgery (exam C), the uKIM in absolute
values (ng/ml) did not differ from those of control 1;
however, when these were corrected for creatinine, the
difference was statistically significant.
The median uNGAL/cr. level was significantly higher in
patients from the study group when compared to those of
control 2. The highest levels of uNGAL/cr. were found in urine
obtainedfromtheaffectedpelvisduringsurgery.Thedifference
between the uNGAL/cr. level from voided urine (median
23.66, range 2.04–60.35 ng/mg cr.) and the affected pelvis
(median: 38.48, range 1.5–131.23 ng/mg cr.) was not statisti-
cally significant (p>0.05). Three months after surgery, the
uNGAL/cr. level had decreased significantly (p<0.05), and did
not differ from control 1 patients (p>0.05), although it was
still higher than that of control 2 patients (p<0.05). Similarly,
the uNGAL/cr. level was significantly higher in control 1
patients than in the healthy control 2 children (p<0.05).
To investigate the effect of pyeloplasty on uKIM-1/cr.
and uNGAL/cr. levels, we analyzed the values before and
after surgery in specific patients. As shown in Fig. 2, after
surgery the uKIM/cr. and uNGAL/cr. levels decreased
significantly in 75 and 90% of patients, respectively.
A negative correlation between the KIM-1/cr. ratio and
DRF was found in the study group (r=–0.312, p<0.01).
Clinical parameters Study group Control 1 Control 2
Median (range)
Gender, n (male/female) 20 (15/ 5) 20 (13/ 7) 25 (14/ 11)
Age at diagnosis (years) 0.29 (0.06–15) 4.5 (0.08–17) –
Age at the moment of examination
(years)
2.16 (0.16–17) 8.75 (0.75–17) 5.0 (0.33–16)
Clinical diagnosis (SFU grading) – 4 –
Grade 1
Grade 2 – 11
Grade 3 9 5
Grade 4 11 –
Laterality (left/right) 15/ 5 11/ 9 –
Differential renal function (%) 39 (10.2–45) 45.8 (35–50) –
Length of affected renal pelvis (mm) 38.5 (21–70) 31.0 (16–41) –
Width of affected renal pelvis (mm) 26.0 (14.5–47) 21.0 (4–35) –
Estimated glomerular filtration rate
(ml/min/1.73 m
2)
154.7 (105.5–223.7) 186.6 (122.2–271.5) 155.0 (111.5–233.7)
Table 1 Summary of the clinical
parameters of all studied
patients
Values given in parenthesis
are the range—unless stated
otherwise
Table 2 Urine concentration of KIM-1 and NGAL in patients with UPJO (study group and control 1) and healthy controls (control 2).
Exam
a/group uKIM-1 (ng/ml) uKIM/cr. (ng/mg cr.) uNGAL (ng/ml) uNGAL/cr. (ng/mg cr.)
Exam A (voided urine before pyeloplasty) 1.35
A, b (0.96–6.76) 3.13
A, b (0.6–10.73) 8.38
A, b (3.3–55.22) 23.66
A, b (2.04–60.35)
Exam B (urine samples from affected
pelvis during surgery)
1.37
b (0.27–5.3) 3.42
B, b (0.19–9.59) 12.43
A, b (1.78–100.0) 38.48
B, b (1.5–131.23)
Exam C (voided urine 3 months
after surgery)
1.41
b (0.6–4.88) 1.73
A, b (0.48–6.94) 3.37
b (1.09–55.3) 5.62
a (2.15–25.78)
Control 1 (children had suspected
but not confirmed UPJO)
0.84
b (0.23–2.71) 1.04 (0.18–5.69) 3.94
b (1.23–12.15) 3.8
a (0.9–44.77)
Control 2 (healthy children) 0.37 (0.15–1.82) 0.58 (0.15–3.01) 1.64 (0.25–5.77) 2.31 (0.27–16.27)
uKIM-1, Urinary kidney injury molecule-1; uNGAL, urinary neutrophil gelatinase-associated lipocalin; cr., creatinine; UPJO, ureteropelvic
junction obstruction
Values are given as the median with the range given in parenthesis
p
A <0.05 to control 1, p
a <0.05 to control 2; p
B <0.01 to control 1, p
b <0.01 to control 2
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levels from the affected pelvis and DRF (r=–0.458, p<
0.01). A negative correlation was also found in control 1
group, but it was not statistically significant (r=-0.213, p>
0.05). We did not find any significant correlation with
serum creatinine level, age of patients, GFR, and initial AP
diameter (length) of the pelvis.
The uNGAL/cr. level was found to be negatively
correlated with DRF (r=−0.422, p<0.05) and positively
correlated with the uKIM/cr. level in children with severe
HN (r=0.377, p<0.05). No significant correlations with
serum creatinine or GFR were found.
ROC analyses were performed to define the diagnostic
profile of uKIM-1 and uNGAL in identifying children with
an obstructive kidney condition (DRF<40%) among chil-
dren with severe and mild HN (study group and control 1)
and children with abnormal DRF (<45%) among all
examined children. In the first analysis in children with
HN, we found that both uKIM-1/cr. and uNGAL/cr. showed
quite good diagnostic profile, describing an area under the
curve (AUC) for uKIM-1/cr. of 0.8 [95% confidence interval
(CI) 0.687–0.914] with a best cut-off value of 0.462 ng/mg
cr. (sensitivity 100%, specificity 71.4%) and an AUC for
uNGAL/cr. of 0.814 (95% CI 0.711–0.917) with a best cut-
off value 2.158 ng/mg cr. (sensitivity 100%, specificity
28.6%). The difference in AUC between uKIM-1/cr. and
uNGAL/cr. was 0.02 (p>0.05). However, the results were
analyzed in two different populations (younger children
with severe HN and older control 1 patients).
In a subsequent analysis, we assessed the sensitivity and
specificity of uKIM-1/cr. and uNGAL/cr. as biomarkers of
kidney injury (DRF<45%). In this analysis, the AUC for
uKIM-1/ cr. was 0.779 (95% CI 0.685–0.873) with a best
cut-off value 0.997 ng/mg cr. (sensitivity 82.4%, specificity
59.5%), and the AUC for uNGAL/cr. was 0.868 (95% CI
0.796–0.939) with a best cut-off value of 4.924 ng/mg cr.
(sensitivity 82.4%, specificity 75.7%). Here, the AUC for
uNGAL/cr. was higher; however the difference between the
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Fig. 1 uKIM-1/cr. (a) and uNGAL/cr. (b) excretion in patients with
severe HN in exam A (before surgery) and exam B (urine from
affected pelvis) and in patients with mild HN (control 1) and healthy
children (control 2). uKIM-1 Urinary kidney injury molecule-1,
uNGAL urinary neutrophil gelatinase-associated lipocalin, cr. creati-
nine, ANOVA analysis of variance
A. uKIM/ cr. B. uNGAL/ cr.  Fig. 2 KIM-1/ cr. (a)a n d
NGAL/ cr. (b) levels in patients
who underwent pyeloplasty
Pediatr Nephrol (2011) 26:579–586 583AUC for uKIM-1/cr. and that for uNGAL/cr. was 0.08 and
not statistically significant (p>0.05).
ROC analyses for uKIM-1 and uNGAL not corrected for
urinary creatinine showed similar values.
Discussion
The future challenges of evaluating and treating patients
with obstructive nephropathy relate to the indications for
surgical intervention and finding prognostic indicators of
renal progression. In clinical practice there are no clear
indications for the timing of surgical intervention to prevent
kidney injury. UPJO accounts for between 35 and 50% of
all significant prenatally detected uropathies. However, the
results of randomized trials suggest that only 19–29% of
children with prenatally diagnosed UPJO require surgical
intervention [18, 19]. In this situation, although diuretic
renography and US evaluation assist the clinician to
establish the presence and degree of UPJO, there is an
urgent need to look for potential biomarkers in patients’
fluids, preferably urine, that would enable the early
detection of obstructive nephropathy and deterioration in
renal function.
We have evaluated the usefulness of KIM-1 and NGAL
as biomarkers of obstructive nephropathy. To assess the
utility of these biomarkers, we compared the magnitude of
the alternation in their concentration in urine at different
periods of time in children with confirmed HN with the
levels in healthy children and in children with mild, non-
obstructive HN. We also calculated the accuracy and
sensitivity of each biomarker in children with HN, accord-
ing to the DRF of the affected kidney in a renal nuclide
scan, using ROC analysis. To the best of our knowledge
this study is the first published report that assesses the
concentration of uKIM-1 and uNGAL in children with HN
due to UPJO. Much progress has been made in the last
decade in evaluating the mechanisms of obstructive
nephropathy in UPJO, with the result that the following
cellular mechanisms have been identified as major players:
(1) tubular dilatation, phenotypic cellular transition, and
cell death, (2) interstitial inflammation, and (3) glomerulo-
tubular injury and progressive interstitial fibrosis [20].
In our study, the uKIM-1 levels were significantly
elevated in patients who had developed an obstructed
kidney but not yet undergone pyeloplasty. Three months
after surgery, the concentration of uKIM-1 had decreased
significantly, but did not reach the values found in children
with dilated, but not obstructed kidney (control 1) (p<
0.05). The uKIM-1 levels of patients from study group
were significantly different from those of both control
groups (p<0.05). In contrast to the study of Ichimura et al.
[10, 11], who did not detect uKIM-1 expression in healthy
kidney, we detected low concentrations of uKIM-1 in the
urine of our healthy controls.
What is the mechanism for increase of KIM-1 in patients
with dilated and obstructed pelvis? KIM-1 is a protein that
is localized at very high levels on the apical membrane of
proximal tubule, which is the region where the tubules are
more affected [21]. It has an ability to phagocytose
apoptotic and necrotic cells in the tubules of the kidney
and thus may be critical for remodeling after injury [22].
Chaturvedi et al. [13] confirmed that KIM-1 expression
persists until the damaged cells have completely recovered,
which might explain the fact that the uKIM-1 level was still
elevated in our study patients 3 months after pyeloplasty.
Interestingly, the difference in uKIM-1 concentration in
voided urine before pyeloplasty and pelvic urine from the
affected kidney was not statistically significant (p>0.05).
One possible explanation for this observation may be that
intact contralateral kidney undergoes compensatory growth
that is proportional to the duration of the obstruction [23].
In this situation, the source of the uKIM-1 in the voided
urine may also be the contralateral kidney. We established a
significant positive correlation between the levels of uKIM-
1 in voided urine and those in the affected pelvis,
suggesting a valuable role for preoperative voided urine
KIM-1 in predicting intrapelvic level.
The levels of uKIM-1 were negatively correlated with
DRF in the radionuclide scan. The strong negative
correlation between uKIM-1 levels in the pelvic urine and
DRF of the affected kidney confirms the observation of
Bonventre et al. [14] who found that uKIM-1 level is
closely related to tissue KIM-1 and correlated with the
severity of renal damage.
If we consider KIM-1 to be an early marker of tubular
injury, we can hypothesize that uKIM-1 may express the
degree of subclinical tubular impairment, thus representing
an earlier measurable marker of its function. Recent data
have confirmed KIM-1 expression in tubules of patients
with various chronic proteinuric diseases, which was
strongly associated with renal fibrosis and inflammation
[15]. This has led to the proposal that KIM-1 can be
considered as a non-invasive biomarker not only of the
proximal tubules but also of chronic tubulointerstitial
damage. This proposal is supported by data from our
ROC analyses, which showed a good diagnostic profile for
uKIM-1 in HN children (study and control 1 groups; AUC
0.8) and only a slightly worse profile for detecting kidney
injury in HN children with DRF<45% (AUC 0.779). The
results may suggest that uKIM-1 may be useful in
identifying the presence of obstruction in HN patients.
The second biomarker analyzed in this study was
uNGAL, which has also been studied extensively in
preclinical and clinical models and found to be a potential
biomarker of number of pathologic conditions (e.g., AKI,
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breast cancer) and a useful tool in disease monitoring of other
renal diseases (e.g., delayed graft function, lupus nephritis,
IgA nephropathy and polycystic disease) [9, 24, 25].
To the best of our best knowledge there are no published
data on uNGAL levels in obstructive nephropathy. How-
ever in the mouse model of unilateral obstruction, NGAL
protein synthesis was dramatically increased in the dilated
thick ascending limb of Henle [8]. The authors found the
increased NGAL levels in urine in the swollen pelvis of the
ligated pelvis.
In our study, uNGAL levels were monitored in the same
groups as was uKIM-1. uNGAL was detected in all of the
healthy control children. In children with an obstructed
kidney, the uNGAL concentration in voided urine (exam A)
was tenfold higher and that in urine from the affected pelvis
(exam B) was more than 16-fold higher than that in control
2 patients. Similar to the results for uKIM-1, uNGAL levels
from the affected pelvis were not significantly higher than
those in the voided urine (p>0.05). Three months following
the surgery, the uNGAL levels had decreased significantly
(p<0.05); however, they were still higher than those
measured in control 2 patients (p<0.05). Comparable to
uKIM-1, uNGAL levels in control 1 children were lower
than those in the study group, bu significantly higher than
those in the healthy controls (p<0.05). In addition, uNGAL
levels correlated with uKIM-1 in children with HN.
A significant inverse correlation between uNGAL
concentration and DRF was found in both the study and
control 1 patients. Interestingly we did not find any
relationship between NGAL concentration and serum
creatinine concentration or GFR. As such, our results differ
from those reported by Bolignano et al. [26], who
confirmed significant correlations between uNGAL con-
centrations and serum creatinine concentration and GFR;
however, their study was performed in patients with CKD.
The lack of the correlation in our study might be explained
by the fact that all of the children enrolled in our study had
normal renal function.
The increased uNGAL levels observed in our study may
express the degree of subclinical tubular impairment. Ding
et al. [9] showed that NGAL protein is highly induced in
proximal tubules in IgAN patients with tubulointerstitial
injury and that this increase in this patient group may be
due to its secretion from proximal tubular epithelial cells
within damaged tubules to induce re-epithelialization.
NGAL has also been found to be a regulator of epithelial
morphogenesis in cultured kidney tubule cells [27].
Furthermore, Mishra et al. [28] suggested a possible role
of NGAL in repairing damaged tubules. Devarajan [29]
suggested that any urinary excretion of NGAL was likely to
be present only when there was concomitant renal tubular
injury that increased de novo NGAL synthesis and/ or
precluded NGAL reabsorption. Increased uNGAL levels
have been postulated to be an early predictor of severity of
the microangiopathic disease and secondary to associated
tubular damage in diarrhea-associated hemolytic uremic
syndrome. Its role as a marker was also confirmed in
kidney transplant recipients in terms of delayed graft
function and acute rejection episodes. In one of our studies,
we proposed that NGAL may be a non-invasive marker for
the early detection of tubulointerstitial damage in cyclo-
sporine A nephrotoxicity [30].
Data from the literature indicate that uNGAL measure-
ment reflects local renal injury, which is the underlying
rationale for it being proposed as a non-invasive marker in
kidney injury due to HN in children. This suggestion is
supported by the data from our ROC analyses, which
showed a good diagnostic profile for uNGAL, possibly
indicating that uNGAL may be of valuable in diagnosing
significant obstruction.
The major limitation of this study is the number of
patients, which is relatively small and does not allow us to
draw an unequivocal conclusion. However, we were also
unable to compare the examined parameters based on a
histological diagnosis. It must also be taken into account
that the increased levels of uKIM-1 and uNGAL may not
only reflect renal tubular cell damage; there may also be
extrarenal sources. Another point is that despite the high
AUC values, the ROC analysis was performed in two
different age populations (those with severe HN who were
relatively younger and those with mild HN who were
relatively older).
In conclusion, the results of our pilot study have
clearly demonstrated that the children of our cohort with
UPJO had increased urinary KIM-1 and NGAL levels
and that these correlated negatively with DRF in the
radionuclide scan. No less important, the results have a
number of important diagnostic implications which have
to be further validated in a larger population. The results
suggest that uNGAL and uKIM-1 levels are associated
with worsening obstruction. However, as this study is not
a true prospective cohort study, we cannot draw the
definitive conclusion that these markers are valuable in
identifying obstruction. Future investigations are required
to confirm a potential application of KIM-1 and NGAL
as a useful biomarkers for such a diagnosis and as a
parameters to prevent the development and progression
of chronic kidney disease.
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